References
- Editorial. Code of practice for the clinical assessment of licensed medicinal products in general practice. Joint agreement between BMA, RCGP, and ABPI. Br Med. J. 1983; 286: 12951. Editorial. Code of practice for the clinical assessment of licensed medicinal products in general practice. Joint agreement between BMA, RCGP, and ABPI. Br Med. J. 1983; 286: 1295
- Hallett C., Dean B. C. Flunitrazepam: acute benefit-risk assessment in general practice. J. Int. Med. Res. 1983; 11: 3382. Hallett C., Dean B. C. Flunitrazepam: acute benefit-risk assessment in general practice. J. Int. Med. Res. 1983; 11: 338
- Inman W. H. W. Postmarketing surveillance of adverse drug reactions in general practice. I. Search for new methods. Br Med. J. 1981; 282: 11313. Inman W. H. W. Postmarketing surveillance of adverse drug reactions in general practice. I. Search for new methods. Br Med. J. 1981; 282: 1131
- Inman W. H. W. Postmarketing surveillance of adverse drug reactions in general practice. II. Prescription-event monitoring at the University of Southampton. B. Med. J. 1981; 282: 12164. Inman W. H. W. Postmarketing surveillance of adverse drug reactions in general practice. II. Prescription-event monitoring at the University of Southampton. B. Med. J. 1981; 282: 1216